T78946 |
MAT2A-IN-10
|
2924825-23-8
|
98%
|
|
MAT2A-IN-10 (Compound 28), an orally active inhibitor of MAT2A, exhibits an IC50 of 26 nM and is utilized in cancer research [1].
|
T79349 |
MAT2A-IN-11
|
|
98%
|
|
MAT2A Allosteric Inhibitor 1, also known as Compound 5, is a selective inhibitor of methionine adenosyltransferase (MAT) demonstrating potent activity with an IC...
|
T79350 |
MAT2A-IN-12
|
631897-75-1
|
98%
|
|
MAT2A Allosteric Inhibitor 2 is a potent, selective inhibitor exhibiting an IC50 of 5 nM and demonstrates nanomolar efficacy (IC50 = 5 μM) in proliferation assay...
|
T14141 |
AGI-24512
|
2201066-53-5
|
98%
|
|
AGI-24512 is a inhibitor of methionine adenosyltransferase 2A (MATA2 ).It is useful for treatment of cancer and blocks growth of MTAP-deleted cancer cells in vit...
|
T10259 |
AGI-25696
|
2201066-35-3
|
98%
|
|
AGI-25696 is an inhibitor of methionine adenosyltransferase 2A (MATA2). AGI-25696 blocks the growth of MTAP-deleted tumors in vivo and can be used for studies ab...
|
T11950 |
MAT2A inhibitor 2
|
13299-99-5
|
99.63%
|
|
MAT2A inhibitor 2 is an inhibitor of methionine adenosyltransferase 2A (MAT2A).
|
T9262 |
MAT2A inhibitor 4
|
1391934-91-0
|
98.86%
|
|
MAT2A Inhibitor 4 acts as an inhibitor targeting the catalytic subunit of methionine S-adenosyltransferase-2 (MAT2A), offering potential utility in cancer resear...
|
T11284 |
FIDAS-3
|
1266684-01-8
|
98.59%
|
|
FIDAS-3, a stilbene derivative and potent Wnt inhibitor with an IC50 of 4.9 μM for methionine S-adenosyltransferase 2A (MAT2A), exhibits anticancer activities by...
|
T73140 |
MAT2A-IN-9
|
2439277-80-0
|
98.53%
|
|
MAT2A-IN-9, a 2-oxoquinazoline derivative, is a potent MAT2A (methionine adenylyltransferase 2A) inhibitor.MAT2A-IN-9 has antitumor activity for the treatment of...
|
T9050 |
AG-270
|
2201056-66-6
|
98.2%
|
|
AG-270 is an allosteric and orally active inhibitor of MAT2A.
|
T5191 |
PF-9366
|
72882-78-1
|
97.28%
|
|
PF-9366 is a human methionine adenosyltransferase 2A (Mat2A) inhibitor (IC50: 420 nM; Kd: 170 nM).
|